Top 50 Medical Startup Investors in Belgium in October 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Belgium. We rank investors based on the number of investments they made in Medical companies from Belgium. We update this investor list every month.Top 50 Medical Startup Investors in Belgium in October 2024
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Funding Round
- Belgium, France, Germany
Portfolio highlights
- Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
- Get Your Way — Discover the future of assisted reality with Get Your Way's aRdent smart glasses. Perfect for SMEs looking for innovative solutions to improve their business
- Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
Oxygen for growth - LRM
Show more
Investment focus
- Information Technology, Software, Biotechnology
- Funding Round, Series A, Seed
- Belgium, United States, The Netherlands
Portfolio highlights
- Cumul.io — Create powerful dashboards in minutes. Share with your teams, or integrate in your platform. Drive growth in your business today!
- MobieTrain — Unlock the potential of your customer-facing employees and create memorable customer experiences with MobieTrain's app.
- Raw Stadia — Raw Stadia is a sports technology company that specializes in surface player interactions.
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Series B, Series A
- Belgium, United States, The Netherlands
Portfolio highlights
- Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
- VoxelSensors — Spatial and Empathic Computing. Bringing empathic abilities to XR and mobile devices by understanding user attention and intent.
- Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel
Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series A, Funding Round, Seed
- Belgium, Japan, France
Portfolio highlights
- AdipoPharma — By harnessing the power of the Adipocyte AdipoPharma is committed to developing innovative treatment for type 2 diabetes
- AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Seed, Funding Round, Series A
- Belgium
Portfolio highlights
- Weavely — Design forms in Figma - publish with Weavely. We turn your visual ideas into interactive, web-based forms.
- Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
- Tanai Therapeutics — Tanai Therapeutics develops novel therapeutics for people living with obesity and obesity-related complications.
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Seed
- Belgium, France, United Kingdom
Portfolio highlights
- Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
- Protealis — Sustainable plant proteins for Europe
- Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century.
Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Funding Round, Series A, Series B
- Belgium, United States, Spain
Portfolio highlights
- Univercells — Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%.Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based onsingle-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
- Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Do and dare company
Show more
Investment focus
- Software, Biotechnology, Health Care
- Series A, Seed, Funding Round
- Belgium, The Netherlands, United States
Portfolio highlights
- Accurat — Accurat provides real-word shopper insights to support retail decision making with unprecedented accuracy. Our proprietary technology, platform and algorithms understand behaviour in high detail.
- PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
- Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- Belgium, United States, Spain
Portfolio highlights
- AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Gemma Frisius Fund KU Leuven is a seed capital fund that aims to stimulate the creation and growth of university related spin-off companies.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series B, Series A
- Belgium, France, United Kingdom
Portfolio highlights
- DName-iT — DName-iT is a genetic analysis tool that offers DNA-based barcode labeling technology and a software platform that can ensure reliable, cost-effective NGS specimen identification.
- Protealis — Sustainable plant proteins for Europe
- Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
Volta Ventures is a venture capital firm, offering seed & early stage VC for internet & software companies (SaaS) in the Benelux region
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Funding Round
- Belgium, The Netherlands, Luxembourg
Portfolio highlights
- Propellant.digital — We are a Netherlands based FinTech that is focused on bring together public and private data to power business decisions in a low cost way. Born in 2021, our mission is to organise financial markets information and make it transparent, accessible, affordable and useful to all parties in the ecosystem. Propellant.Digital is headed up by foundersVincent Grandjean, and Allan Horgan, both professionals who have a long history in the financial market technology sector and wanted to leverage their experience to create a solution that was low cost.
- Fero — Welcome to FERO
- Ecochain Technologies — Ecochain is a life cycle assessment software and services company that helps companies reduce their environmental footprint. Learn more.
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more
Investment focus
- Information Technology, Medical, Software
- Funding Round, Seed, Series A
- Switzerland, Germany, United Kingdom
Portfolio highlights
- LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
- AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
- Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Convertible Note, Series A
- Belgium
Portfolio highlights
- IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
- Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
For game changers in medtech
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Series B
- Belgium
Portfolio highlights
- Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
- Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
- Clouds of care — CLOUDS OF CARE aids HealthTech firms from algorithm validation to medical device software, focusing on regulatory compliance.
Flanders Future Techfund operates as an investment firm.
Show more
Investment focus
- Medical, Semiconductor, Clinical Trials
- Seed
- Belgium
Portfolio highlights
- Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
- Clouds of care — CLOUDS OF CARE aids HealthTech firms from algorithm validation to medical device software, focusing on regulatory compliance.
- Swave Photonics — Swave develops Spatial Computing, Holography, holographic chips, and holograms in the HXR chip to create 3D augmented and virtual reality and HUD Heads Up Displays
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
- Navigator Medicines — Leading the advancement of biologics for targeted immune regulation & restoration.
- Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Buysse and Partners is a private equity investment group based in Antwerpen that offers smart equity, a growth fund, and partnerships.
Show more
Investment focus
- Software, Cloud Computing, FinTech
- Series A, Seed, Funding Round
- Belgium, United Kingdom, The Netherlands
Portfolio highlights
- Twikit — Discover Twikit's 3D product configurator software with manufacturing workflows.
- Bluebee — Delivering a streamlined way for users to analyze, explore, and manage large-scale genomics data in the cloud.
- moonbird — Slow breathing is the easiest way to relieve stress and promote relaxation. Moonbird makes it intuitive and easy to do breathing exercises.
Shaping new life-science ventures.
Show more
Investment focus
- Biotechnology, Therapeutics, Health Care
- Funding Round, Series A, Seed
- The Netherlands, United States, United Kingdom
Portfolio highlights
- Tanai Therapeutics — Tanai Therapeutics develops novel therapeutics for people living with obesity and obesity-related complications.
- Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
- Brenig Therapeutics — Brenig Therapeutics develops therapies for neurodegenerative disorders.
Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP
currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Private Equity, Funding Round
- France, Belgium, United Kingdom
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
- Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
- Broken String Biosciences — Our platform accelerates the characterisation of novel gene editing technologies to unlock the next wave of cell & gene therapies.
BAN Vlaanderen is the business angel network in Flanders, a value-added platform within which new or growing businesses are brought into contact with informal private investors, called Business Angels. Looking for venture capital This Business Angels bring not only money but also their own know-how, experience and contacts. Are connecting servicesoffered. Both the entrepreneurs and the business angelsBAN Vlaanderen is no investment, it does not own shares or take any investment decisions, nor for its own account or on behalf of the affiliates. Instead, it is a market where supply and demand are brought together. The information on this site is intended to initiate the purpose and operation of BAN Vlaanderen. For more information you can always contact one of our regional offices.BAN Vlaanderen is an association that aims to stimulate the development, support and promotion of entrepreneurship and investment culture in Belgium. Economic growth in Belgium
Show more
Investment focus
- Health Care, Medical, Apps
- Funding Round, Seed, Series A
- Belgium
Portfolio highlights
- OutKept — Can you be phished? Verhoog je bewustzijn en naleving met volledig geautomatiseerde phishing-simulaties gemaakt door een community van ethische phishers.
- Pom — POM stands for Peace of Mind. And it's exactly that worry-free feeling that they want their customers to achieve through their invoice management solutions, both for the receiver and the sender.Their goal is to eliminate the senseless time and effort spent because of inefficient systems. And thus freeing up time to do the things that reallymatter.
- Oncomfort — Oncomfort’s solution for digital sedation is a completely new method for relieving patients’ pain and anxiety before, during and after medical procedures. This revolutionising digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality.
Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Series A, Series B
- Belgium, France, Spain
Portfolio highlights
- cikisi — Specialized in Web Intelligence (collecting, searching and filtering web information). Help companies and organizations to take advantage of Web information that are relevant to their development. Develops and commercializes Cikisi WMT, a Web Intelligence Solution.
- AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège.
It is headquartered in Angleur, Belgium.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Funding Round
- Belgium
Portfolio highlights
- Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
- Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
- Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
- Medical, Analytics, Health Care
- Funding Round, Series A
- Belgium
Portfolio highlights
- MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
- DeuterOncology — DeuterOncology is a preclinical-stage biotech company focusing on the development of a first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies.
- Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.
Show more
Investment focus
- Health Care, Manufacturing, Biotechnology
- Series A, Seed, Funding Round
- Belgium, France, United Kingdom
Portfolio highlights
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
- Octave — A sustainable, cost-effective and reliable energy storage system with second-life batteries from electric vehicles.
Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors.
The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Funding Round
- Belgium, France, Spain
Portfolio highlights
- Savics — Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
- DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
- NIUM — NIUM is a startup focused on personalized nutrition and gut microbiome research. NIUM created science-based solutions to transform nutrition research and product development.
Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Series A, Funding Round, Series B
- France, Germany, United States
Portfolio highlights
- Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
- Carbyon — Carbyon is a Netherlands-based company that develops direct air capture (DAC) technologies. The company's fuels help to replace fossil hydrocarbons with electrical batteries or hydrogen (H2), alternative energy carriers that are used to store renewable electricity and make major changes to transportation facilities, energy grids, and gastransportation networks, filters CO2 from the air and supply it in a purified form to make kerosene for aircraft, enabling existing fossil industry to re-use and repurpose these storage and transport facilities for renewable hydrocarbons.
- Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Seed
- The Netherlands, Belgium, United States
Portfolio highlights
- Pan Cancer — Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer.
- Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
- Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- Belgium, Germany, The Netherlands
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- inHEART — inHEART is a spin-off from IHU Liryc and Inria, two top-tier research centers respectively in cardiac electrophysiology and digital science and technology, that develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology to become aworldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Integrale Advisors L.L.C. is a Real Estate Investment, Advisory and Business Development Firm.
Show more
Investment focus
- Medical, Health Care, Therapeutics
- Series A
- Belgium
Portfolio highlights
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Limburg Ventures is a venture capital fund that invests in startups in life sciences and related fields of advanced chemicals and materials.
Show more
Investment focus
- Biotechnology, Life Science, Health Care
- Funding Round, Series A, Series B
- The Netherlands, France, Belgium
Portfolio highlights
- FABPulous — FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, HealthInnovations, Limburg Ventures and NV Industriebank LIOF.The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.
- Kriya Materials — Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles as well as their downstream dispersions and functional coating products thereof. Coatings play an important role in our everyday life, although often not recognized by those who do not master the art. Coatings are a big market and many products fallunder this category. Kriya Materials focuses itself on the development and manufacturing of various nano metal oxides which it uses internally for the development and production of very high end coatings.The coatings made by Kriya Materials are applied in a wide range of markets, some examples are the Plasma Panel and LCD industry, from Smartphone to touch panels to glass surfaces.
- ReSolved Technologies — ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more
Investment focus
- Software, Information Technology, Health Care
- Series A, Seed, Series B
- Germany, United States, United Kingdom
Portfolio highlights
- Loyi — Loyi is a loyalty platform. Its no-code, white-label solutions provide individualized, gamified experiences.
- TILT — TILT app allow users to discover small brands, buy through videos, livestreams, and eard rewards.
- Involve Space — Involve Space provides solutions for space-based activities via a customizable and cost-effective stratospheric pseudo satellite.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Dental Innovation Alliance (DIA) is a venture capital company that invests in, advises on, and accelerates the growth of early-stage companies that are transforming dentistry through technology.
Show more
Investment focus
- Software, Health Care, SaaS
- Series A, Seed, Funding Round
- Belgium, Germany, Switzerland
Portfolio highlights
- Relu — Integrate Relu's automatic 3D segmentations seamlessly into your CBCT software.
- Odne — Curing with light
- Dentognostics GmbH — Dentognostics is a reasearch based firm that offers medicine and dentistry innovative and powerful systems for diagnostics, and therapy.
New Economy Startups Investor & Accelerator
Show more
Investment focus
- Software, Music, Information Technology
- Seed, Funding Round, Series A
- Belgium, France, United States
Portfolio highlights
- Raw Stadia — Raw Stadia is a sports technology company that specializes in surface player interactions.
- CityLegends — A home for urban sports & culture partners of CityLegends. Making the lines.
- Streamforge — Streamforge helps companies find the most relevant creators for their games and products using the most sophisticated platform and technology on the market.
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, The Netherlands, Switzerland
Portfolio highlights
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
- Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. We invest in the most promising life science companies.
Show more
Investment focus
- Biotechnology, Medical, Pharmaceutical
- Series A, Series B, Series C
- United States, Belgium, The Netherlands
Portfolio highlights
- Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
- Frontier Medicines — Frontier Medicines is boldly advancing science to defeat disease by pioneering innovations in precision-based medicines to target undruggable therapies
- Accent Therapeutics — Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth anddifferentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Seed, Series B
- Switzerland, United States, France
Portfolio highlights
- Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
- OmicsChart — OmicsChart is an oncology data company on a mission to revolutionize precision oncology by building a patient-centred cancer data ecosystem, consolidating scattered data, promoting transparency, and advancing clinical research with machine learning on real-world datasets. Our flagship product PREON is an analytics platform for cancer biologists.
- MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation.
The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Private Equity, Funding Round
- France, United States, Germany
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Skysun — Skysun is a financial institution that provides financial solutions and services to the solar energy sector.
- Kestra Medical Technologies, Inc. — Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, and mobile. They provide intuitive medical technologies to protect and support at-risk patients.
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Seed, Series A
- Ireland, United States, United Kingdom
Portfolio highlights
- Imvizar — Imvizar focuses on life-size, location-based experiences that allow users to feel as if they've gone back in time, meeting renowned individuals and witnessing historical events all from the comfort of their own phone. Imvizar was founded by Michael Guerin and is located in Dublin, Ireland.
- ZeroMission — ZeroMission is a technology focused provider of integrated data for intelligent fleet electrification planning, operations and reporting.
- MarketSizer — MarketSizer offers subscription-based competitive intelligence and market insights for SaaS vendors who want to strategically grow their business.
A limited company of the University of Liège (ULiege).
Show more
Investment focus
- Medical, Software, Wellness
- Seed, Series C, Funding Round
- Belgium
Portfolio highlights
- Phasya — Phasya offers solutions for detecting drowsiness and measuring eye movements. These solutions are based on eye tracking technologies using eye images. Phasya also develops solutions for detecting various physiological and cognitive states such as stress, attention, cognitive load, and mind wandering.Phasya solutions can be used in variousapplications such as safety, medical diagnosis, and research. We have notably specific solutions and developments for driver monitoring applications.Indeed physiological and cognitive states such as drowsiness influence the ability of an individual to perform a task or to make a decision. Furthermore the measurement of ocular parameters enables one to understand the brain activity and gaze behavior.
- Ampacimon — Ampacimon develops dynamic line rating systems for transmission and distribution systems operators. Ampacimon’s products address grid infrastructure challenges such as aging assets, transmissions congestion, renewable integration, interconnectors.
Specializes in spin-off and spin-out investments.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A
- Belgium
Portfolio highlights
- Synergia Medical — Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators.In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputeeprosthesis arm and developed its first version of the NAOS platform.Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.
BNP Paribas Fortis is a bank that provides personal and business banking services.
Show more
Investment focus
- Biotechnology, Logistics, Pharmaceutical
- Debt Financing, Funding Round, Series B
- Belgium, United States, Germany
Portfolio highlights
- Aphea.Bio — Aphea.Bio will develop next generation ‘biopesticides’ based on natural microorganisms. These products will provide an alternative for chemical pesticides, which are currently under serious pressure. In addition, the company will develop novel ‘biostimulants’, i.e. microorganisms that stimulate crop growth, for example through promoting the uptakeof nutrients from the soil.
- MobieTrain — Unlock the potential of your customer-facing employees and create memorable customer experiences with MobieTrain's app.
- Global Infrastructure Partners — A leading global, independent infrastructure fund manager.
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- Samp — Samp accelerates modernization and de-risks contracts by connecting outdated drawings with current 3D reality captures of your facilities using our AI.
- become.1 — become.1 is an employee benefits platform that eliminates the complexity of tax regulations for employees.
- Symphera — An all-in-one surgical system that makes minimally-invasive procedures more efficient.
Gimv, a trusted European investment company, helps mid-market businesses create sustainable value through growth capital and expertise across diverse sectors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Funding Round, Private Equity
- Belgium, United States, France
Portfolio highlights
- Curana — Curana is a manufacturer of bike equipment and accessories.
- Onward — Working to restore movement, independence, and health in people with spinal cord injury.
- Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
The CoFoundry helps entrepreneurs transform their ideas into sustainable companies. Some say we cut through the funding hype and work hard to give your business a sustainable future.
Show more
Investment focus
- Software, Network Security, SaaS
- Seed, Series A, Funding Round
- Belgium, The Netherlands, United States
Portfolio highlights
- Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
- MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
- Vaultspeed — Save your teams months of headache with a no-code approach to automate your multi-source data integration, Data Vault modeling & ETL/DDL code generation.
The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Funding Round, Series B, Series A
- Belgium, United States, France
Portfolio highlights
- Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
- Univercells — Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%.Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based onsingle-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
- Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
NV Industriebank LIOF is the Limburg development and investment company. LIOF contributes to the prosperity of the province with an ongoing program to strengthen the province's economic base. LIOF targets industry and the dynamic service sector.Its four core activities are Acquisition, Participation, Development/Innovation andBusiness Parks, as these relate to the location/relocation of (foreign) companies, venture capital participation in Limburg companies with prospects, the development/implementation of programs and projects to sharpen the competitive edge of Limburg business and the coordination of the development of new business parks.LIOF has a strategic approach which targets opportunities for long-term economic development. In this it has a bridging role between government and business. LIOF is an ambitious professional organization and speaks the language that business understands.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Seed
- The Netherlands, Belgium
Portfolio highlights
- Ansana — Ansana develops sterilization solutions for the pharmaceutical and healthcare industries. This technology is significantly cutting patient risk, reducing the environmental imprint, lowering expenses, and increasing flow.
- Mosa Meat — Mosa Meat produces slaughter-free hamburgers. The burger is harvested from cow cells, rather than raising and slaughtering a whole animal. By growing meat naturally from cells, Mosa Meat strives to accelerate the transition to a truly sustainable global food system.
- SpecifAi Parking — Maximize your revenue, increase your efficiency and streamline your parking operation.
Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies.It focuses on the innovative technologies in therapeutics, diagnostics, and medical devices. The firm is a sub-organization of Yongjin Group and the sister firm of Yonghua Capital.The Cambridge, Massachusetts-based firm was establishedin 2018.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- HistoSonics — HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
- Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
- Bluejay Therapeutics — Bluejay Therapeutics, Inc. is a private biopharmaceutical company illuminating a path toward curative treatments for viral infections and liver diseases, including for CHB and CHD.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Retail
Financial Services
Infrastructure
Social Media
Medical
Email
Art
Wellness
Music
Mobile
Franchise
Social Network
Local
Internet
Digital Media
Construction
Manufacturing
eSports
Platforms
Sports
Mobile Advertising
Biotechnology
Hospitality
Fitness
Enterprise Software
Travel
Recruiting
Cannabis
Wine And Spirits
Medical Device
Crowdfunding
Social
Automotive
Legal
Android
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Media (entertainment)
Agriculture (agtech)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Morocco
Chile
Malta
Mali
Malaysia
Bermuda
Belize
Georgia
Italy
Greece
Peru
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Turkey
Serbia
Rwanda
El Salvador
Venezuela
Ukraine
Portugal
Sierra Leone
Zimbabwe
Sweden
Taiwan
Senegal
Uruguay
Lithuania
Uganda
Myanmar
Lebanon
Tunisia
Kuwait
Cayman Islands
Cambodia
Israel
San Marino
Panama
Slovenia
Mexico
Zambia
Kazakhstan
Uzbekistan
Liberia
Russian Federation
Jersey
Philippines
Norway
Seychelles
Mauritius
Kenya
Thailand
Liechtenstein
Nicaragua
Dominican Republic
Nigeria
Azerbaijan
Namibia
Iceland
Puerto Rico
Iraq
Bahamas
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Grenada
Jordan
Romania
Argentina
Bangladesh
Tajikistan
Togo
Poland
Tanzania
Austria
Latvia
Cyprus
Oman
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Belgium by industry
Restaurants
InsurTech
Financial Services
Big Data
Cryptocurrency
Finance
Food and Beverage
Medical
Wellness
Medical Device
Consumer
Internet
Social Network
Manufacturing
Digital Media
Mobile
Blockchain
Non Profit
Legal
Construction
Software
Sports
Payments
Enterprise Software
Fitness
Hospitality
Automotive
Recruiting
Mobile Advertising
Platforms
Biotechnology
Enterprise
Health Care
Biotech
EdTech
Climate
Energy
Sustainability
Impact
SaaS
Proptech
Marketplace
Artificial intelligence
Community
Real Estate
Mobile Apps
Infrastructure
Fashion
B2B
Web3
Photography
Life Science
Publishing
Clean Energy
Education
Renewable Energy
Transportation
Music
Retail
FinTech
Gaming
Social Media
Hardware
Media (entertainment)
CleanTech
Agriculture (agtech)